No connection

Search Results

CLB

BEARISH
$17.45 Live
Core Laboratories Inc. · NYSE
Target $16.33 (-6.4%)
$9.72 52W Range $20.36

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$803.54M
P/E
27.7
ROE
11.6%
Profit margin
5.6%
Debt/Equity
0.6
Dividend yield
0.23%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
CLB exhibits a concerning divergence between its current market price ($17.45) and its deterministic value markers, with a Piotroski F-Score of 4/9 indicating only stable health. The stock is trading at a significant premium to both its Graham Number ($9.04) and Intrinsic Value ($4.41), while experiencing a sharp YoY earnings decline of 31.60%. Despite a strong 1-year price rally, the underlying fundamentals—specifically the negative earnings growth and bearish technical trend—suggest the current valuation is unsustainable.

Key Strengths

Strong liquidity with a Current Ratio of 2.02
Manageable leverage with a Debt/Equity ratio of 0.60
Consistent history of beating earnings estimates (3/4 last 4 quarters)
Positive revenue growth (7.00% YoY)
Low payout ratio (6.35%) providing ample room for dividend growth

Key Risks

Severe overvaluation relative to Graham Number and Intrinsic Value
Significant contraction in earnings growth (-31.60% YoY)
Bearish technical trend score (0/100)
Thin profit margins (5.64%)
Negative 5-year price performance (-37.7%)
AI Fair Value Estimate
Based on comprehensive analysis
$9.04
-48.2% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
38
Weak
Value
20
Future
30
Past
50
Health
60
Dividend
30
AI Verdict
Overvalued with deteriorating earnings
Key drivers: Price-to-Intrinsic Value gap, Negative Earnings Growth, Stable but not strong Piotroski score
Confidence
90%
Value
20/100

Ref P/E 27.70, Graham Number $9.04

Positives
  • Forward P/E is lower than current P/E
Watchpoints
  • Price is 92% above Graham Number
  • Price is 294% above Intrinsic Value
Future
30/100

Ref Growth rates

Positives
  • Modest revenue growth (7%)
Watchpoints
  • Earnings growth is deeply negative (-31.60%)
  • PEG ratio of 1.44 suggests overpayment for growth
Past
50/100

Ref Historical trends

Positives
  • Strong 1-year recovery (+50.7%)
Watchpoints
  • Poor 5-year trajectory (-37.7%)
Health
60/100

Ref Piotroski F-Score

Positives
  • Current Ratio > 2.0
  • Debt/Equity is below sector average
Watchpoints
  • Piotroski F-Score is only 4/9
Dividend
30/100

Ref Yield, Payout

Positives
  • Very low payout ratio
Watchpoints
  • Negligible yield (0.23%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$17.45
Analyst Target
$16.33
Upside/Downside
-6.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CLB and closest competitors.

Updated 2026-04-24
CLB
Core Laboratories Inc.
Primary
5Y
-37.7%
3Y
-16.6%
1Y
+50.7%
6M
+3.6%
1M
+10.1%
1W
+5.8%
HPK
HighPeak Energy, Inc.
Peer
5Y
-15.8%
3Y
-72.1%
1Y
-24.0%
6M
-3.5%
1M
+8.4%
1W
-8.1%
HNR
Hallador Energy Company
Peer
5Y
+660.0%
3Y
+61.9%
1Y
+21.6%
6M
-25.0%
1M
-19.7%
1W
-4.0%
CLN
Clean Energy Fuels Corp.
Peer
5Y
-80.6%
3Y
-43.2%
1Y
+77.6%
6M
-4.2%
1M
+8.6%
1W
+2.4%
ACD
ProFrac Holding Corp.
Peer
5Y
-64.9%
3Y
-60.3%
1Y
-11.8%
6M
+69.3%
1M
+14.0%
1W
+17.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
27.7
Forward P/E
20.17
PEG Ratio
1.44
P/B Ratio
3.02
P/S Ratio
1.53
EV/Revenue
1.81
EV/EBITDA
14.33
Market Cap
$803.54M

Profitability

Profit margins and return metrics

Profit Margin 5.63%
Operating Margin 10.93%
Gross Margin 20.69%
ROE 11.59%
ROA 5.53%

Growth

Revenue and earnings growth rates

Revenue Growth +7.0%
Earnings Growth -31.6%
Q/Q Revenue Growth +6.98%
Q/Q Earnings Growth -33.2%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.6
Moderate
Current Ratio
2.02
Strong
Quick Ratio
1.35
Good
Cash/Share
$0.49

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
18.1%
Op. Margin
11.6%
Net Margin
3.6%
Total Assets
$0.6B
Liabilities
$0.3B
Equity
$0.3B
Debt/Equity
1.17x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
52%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-29
$N/A
2026-02-04
$0.21
+10.5% surprise
2025-10-22
$0.22
+13.8% surprise
2025-07-23
$0.19
+5.6% surprise

Energy Sector Comparison

Comparing CLB against 73 companies in the Energy sector (4 bullish, 26 neutral, 43 bearish)
P/E Ratio
27.7
This Stock
vs
32.49
Sector Avg
-14.7% (Discount)
Return on Equity (ROE)
11.59%
This Stock
vs
4.94%
Sector Avg
+134.5% (Excellent)
Profit Margin
5.63%
This Stock
vs
7.04%
Sector Avg
-19.9% (Weaker)
Debt to Equity
0.6
This Stock
vs
1.48
Sector Avg
-59.2% (Less Debt)
Revenue Growth
7.0%
This Stock
vs
26.9%
Sector Avg
-74.0% (Slower)
Current Ratio
2.02
This Stock
vs
2.27
Sector Avg
-10.7% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

CARNES MARTHA Z
Director
Stock Award
2026-04-01
8,069 shares
KLINGENSMITH HARVEY ROBERT
Director
Stock Award
2026-04-01
8,069 shares
TEMENG KWAKU
Director
Stock Award
2026-04-01
8,069 shares
MURRAY KATHERINE
Director
Stock Award
2026-04-01
8,069 shares
ANASTASIO CURTIS V
Director
Stock Award
2026-04-01
8,069 shares
MARTINOVICH ROBERT F
Director
Stock Award
2026-04-01
8,069 shares
HILL CHRISTOPHER SCOTT
Chief Financial Officer
Stock Award
2025-12-31
61,417 shares
BRUNO LAWRENCE
Chief Executive Officer
Stock Award
2025-12-31
180,722 shares
TATTOLI MARK DAMIAN
General Counsel
Stock Award
2025-12-31
24,952 shares
GRESHAM GWENDOLYN Y
Officer
Stock Award
2025-12-31
24,952 shares
TEO SOW HANG
Officer and Treasurer
Stock Award
2025-12-01
864 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-03-31

CLB filed a Definitive Proxy Statement (DEF 14A) on March 31, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

8-K
8-K
2026-03-23

Columbian Banking Corporation filed an 8-K, likely to announce its financial results or a material corporate update.

10-K
10-K
2026-03-23

CLB filed its annual 10-K report on March 23, 2026. The provided excerpts do not contain specific financial metrics or detailed risk disclosures.

8-K/A
8-K/A
2026-03-17

Columbian Banking Corporation filed an amendment to a previously submitted Current Report on Form 8-K.

8-K
8-K
2026-03-05

Columbian Banking Corporation filed a current report on March 5, 2026, likely to announce its year-end financial results or a dividend declaration.

8-K
8-K
2026-02-04

Columbian Banking Corporation filed an 8-K on February 4, 2026, likely to report its fourth-quarter and full-year financial results.

10-Q
10-Q
2025-10-23

CLB filed its 10-Q on October 23, 2025. The provided excerpt identifies the presence of Risk Factors under Item 1A, although specific financial highlights and detailed risk disclosures were not included in the available text.

8-K
8-K
2025-10-22

Columbian Banking Corporation filed an 8-K on October 22, 2025, likely to announce its third-quarter financial results.

10-Q
10-Q
2025-07-25

CLB filed its quarterly 10-Q report on July 25, 2025. The provided excerpt identifies the inclusion of Risk Factors under Item 1A, although specific financial highlights and detailed risk descriptions were not available in the text.

8-K
8-K
2025-07-23

Colliers International (CLB) likely filed this 8-K to announce its second-quarter financial results.

8-K
8-K
2025-05-27
10-Q
10-Q
2025-04-28
8-K
8-K
2025-04-23
DEF 14A
DEF 14A
2025-03-31
10-K
10-K
2025-02-13
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning CLB from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile